Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

Articles published in
Cancer Cell
    September 2025
  1. SATPATHY S, Clark NM, Chen YJ, Hosseini N, et al
    Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures.
    Cancer Cell. 2025;43:1731-1757.
    >> Share

  2. HE D, Wu Q, Tian P, Liu Y, et al
    Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps.
    Cancer Cell. 2025;43:1622-1636.
    >> Share

    July 2025
  3. BENTON A, Liu J, Poussin MA, Lang Goldgewicht A, et al
    Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy.
    Cancer Cell. 2025;43:1365-1376.
    >> Share

  4. GALAN-COBO A, Vokes NI, Qian Y, Molkentine D, et al
    KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer.
    Cancer Cell. 2025 Jul 5:S1535-6108(25)00261-2. doi: 10.1016/j.ccell.2025.
    >> Share

  5. DIJKSTRA KK, Vendramin R, Karagianni D, Witsen M, et al
    Subclonal immune evasion in non-small cell lung cancer.
    Cancer Cell. 2025 Jul 1:S1535-6108(25)00262-4. doi: 10.1016/j.ccell.2025.
    >> Share

    June 2025
  6. ZHU B, Chen P, Aminu M, Li JR, et al
    Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception.
    Cancer Cell. 2025;43:1125-1140.
    >> Share

  7. BALASUBRAMANIAN A, Asselin-Labat ML
    Immune evolution in pre-invasive lung adenocarcinoma.
    Cancer Cell. 2025;43:1004-1006.
    >> Share

  8. GURUNG S, Budden T, Mallela K, Jenkins B, et al
    Stromal lipid species dictate melanoma metastasis and tropism.
    Cancer Cell. 2025;43:1108-1124.
    >> Share

    May 2025
  9. TENG M, Guo J, Xu X, Ci X, et al
    Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation.
    Cancer Cell. 2025;43:891-904.
    >> Share

  10. LI Y, Oser MG
    A circular RNA in neuroendocrine carcinomas.
    Cancer Cell. 2025;43:812-814.
    >> Share

    February 2025
  11. CHEN H, Deng C, Gao J, Wang J, et al
    Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer.
    Cancer Cell. 2025 Feb 14:S1535-6108(25)00030-3. doi: 10.1016/j.ccell.2025.
    >> Share

  12. HENICK BS, Taylor AM, Nakagawa H, Wong KK, et al
    Squamous cell cancers of the aero-upper digestive tract: A unified perspective on biology, genetics, and therapy.
    Cancer Cell. 2025;43:178-194.
    >> Share

    December 2024
  13. HANGGI K, Li J, Gangadharan A, Liu X, et al
    Interleukin-1alpha release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity.
    Cancer Cell. 2024;42:2015-2031.
    >> Share

    October 2024
  14. FU M, Zhao J, Zhang L, Sheng Z, et al
    Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade.
    Cancer Cell. 2024 Oct 9:S1535-6108(24)00360-X. doi: 10.1016/j.ccell.2024.
    >> Share

    September 2024
  15. XU J, Wan R, Cai Y, Cai S, et al
    Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer.
    Cancer Cell. 2024;42:1598-1613.
    >> Share

    August 2024
  16. MCRAE HM, Hargreaves DC
    Transcription factor dependencies identify BAF-dependent cancers.
    Cancer Cell. 2024;42:1326-1328.
    >> Share

  17. HE T, Xiao L, Qiao Y, Klingbeil O, et al
    Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies.
    Cancer Cell. 2024;42:1336-1351.
    >> Share

    July 2024
  18. DUPLAQUET L, So K, Ying AW, Pal Choudhuri S, et al
    Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer.
    Cancer Cell. 2024 Jul 17:S1535-6108(24)00237-X. doi: 10.1016/j.ccell.2024.
    >> Share

    June 2024
  19. ZHOU Q, Pan Y, Yang X, Zhao Y, et al
    Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial.
    Cancer Cell. 2024 Jun 11:S1535-6108(24)00192-2. doi: 10.1016/j.ccell.2024.
    >> Share

    May 2024
  20. MCGINNIS CS, Miao Z, Superville D, Yao W, et al
    The temporal progression of lung immune remodeling during breast cancer metastasis.
    Cancer Cell. 2024 May 24:S1535-6108(24)00167-3. doi: 10.1016/j.ccell.2024.
    >> Share

  21. FINLAY JB, Ireland AS, Hawgood SB, Reyes T, et al
    Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer.
    Cancer Cell. 2024 May 20:S1535-6108(24)00164-8. doi: 10.1016/j.ccell.2024.
    >> Share

  22. LIU SY, Feng WN, Wu YL
    Immunotherapy in resectable NSCLC: Answering the question or questioning the answer?
    Cancer Cell. 2024;42:727-731.
    >> Share

    March 2024
  23. HU F, Lito P
    Insights into how adeno-squamous transition drives KRAS inhibitor resistance.
    Cancer Cell. 2024;42:330-332.
    >> Share

  24. HE XY, Gao Y, Ng D, Michalopoulou E, et al
    Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment.
    Cancer Cell. 2024;42:474-486.
    >> Share

    February 2024
  25. TONG X, Patel AS, Kim E, Li H, et al
    Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer.
    Cancer Cell. 2024 Feb 20:S1535-6108(24)00036-9. doi: 10.1016/j.ccell.2024.
    >> Share

  26. LIU NN, Yi CX, Wei LQ, Zhou JA, et al
    The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells.
    Cancer Cell. 2024;42:318-322.
    >> Share

  27. HUANG DD, Yang JC
    Re-inventing a better wheel? Serplulimab for squamous cell lung cancer.
    Cancer Cell. 2024;42:172-174.
    >> Share

  28. BENGUIGUI M, Cooper TJ, Kalkar P, Schif-Zuck S, et al
    Interferon-stimulated neutrophils as a predictor of immunotherapy response.
    Cancer Cell. 2024;42:253-265.
    >> Share

  29. NABET BY, Hamidi H, Lee MC, Banchereau R, et al
    Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade.
    Cancer Cell. 2024 Feb 9:S1535-6108(24)00015-1. doi: 10.1016/j.ccell.2024.
    >> Share

    January 2024
  30. HEEKE S, Gay CM, Estecio MR, Tran H, et al
    Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.
    Cancer Cell. 2024 Jan 24:S1535-6108(24)00006-0. doi: 10.1016/j.ccell.2024.
    >> Share

  31. MEMON D, Schoenfeld AJ, Ye D, Fromm G, et al
    Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.
    Cancer Cell. 2024 Jan 9:S1535-6108(23)00441-5. doi: 10.1016/j.ccell.2023.
    >> Share

  32. CORDS L, Engler S, Haberecker M, Ruschoff JH, et al
    Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer.
    Cancer Cell. 2024 Jan 8:S1535-6108(23)00449-X. doi: 10.1016/j.ccell.2023.
    >> Share

    December 2023
  33. ZHOU C, Hu Y, Arkania E, Kilickap S, et al
    A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004).
    Cancer Cell. 2023 Dec 21:S1535-6108(23)00432-4. doi: 10.1016/j.ccell.2023.
    >> Share

  34. DAYTON TL, Alcala N, Moonen L, den Hartigh L, et al
    Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites.
    Cancer Cell. 2023;41:2083-2099.
    >> Share

  35. GERSTBERGER S, Ganesh K
    NEN in a dish: A patient-derived organoid biobank illuminates potential novel therapeutic opportunities for neuroendocrine neoplasms.
    Cancer Cell. 2023;41:2014-2016.
    >> Share

  36. CHEN CC, Tran W, Song K, Sugimoto T, et al
    Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation.
    Cancer Cell. 2023;41:2066-2082.
    >> Share

    November 2023
  37. JIAGGE E, Jin DX, Newberg JY, Perea-Chamblee T, et al
    Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers.
    Cancer Cell. 2023;41:1963-1971.
    >> Share

  38. RAHAL Z, Kadara H
    Beyond bacteria: How the intratumor mycobiome modulates lung adenocarcinoma progression.
    Cancer Cell. 2023;41:1846-1848.
    >> Share

    October 2023
  39. RODILLA AM, Valanparambil RM, Mack PC, Hsu CY, et al
    Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer.
    Cancer Cell. 2023 Oct 13:S1535-6108(23)00350-1. doi: 10.1016/j.ccell.2023.
    >> Share

  40. PAN Y, Zhang JT, Gao X, Chen ZY, et al
    Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients.
    Cancer Cell. 2023;41:1763-1773.
    >> Share

  41. LI Z, Lu S
    Integrating minimal residual disease monitoring into clinical practice for NSCLC: Is the era upon us?
    Cancer Cell. 2023;41:1699-1701.
    >> Share

    September 2023
  42. ZHU M, Kim J, Deng Q, Ricciuti B, et al
    Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden.
    Cancer Cell. 2023 Sep 26:S1535-6108(23)00322-7. doi: 10.1016/j.ccell.2023.
    >> Share

  43. LIU NN, Yi CX, Wei LQ, Zhou JA, et al
    The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells.
    Cancer Cell. 2023 Sep 19:S1535-6108(23)00288-X. doi: 10.1016/j.ccell.2023.
    >> Share

  44. TOPP BG, Channavazzala M, Mayawala K, De Alwis DP, et al
    Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression.
    Cancer Cell. 2023;41:1680-1688.
    >> Share

  45. MEGYESFALVI Z, Heeke S, Drapkin BJ, Solta A, et al
    Unfolding the secrets of small cell lung cancer progression: Novel approaches and insights through rapid autopsies.
    Cancer Cell. 2023;41:1535-1540.
    >> Share

  46. CHEN K, Yang F, Shen H, Wang C, et al
    Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer.
    Cancer Cell. 2023 Sep 1:S1535-6108(23)00286-6. doi: 10.1016/j.ccell.2023.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016